D-Serine: Potential Therapeutic Agent and/or Biomarker in Schizophrenia and Depression?
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
D-Serine: Potential Therapeutic Agent and/or Biomarker in Schizophrenia and Depression?
Authors
Keywords
-
Journal
Frontiers in Psychiatry
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-02-06
DOI
10.3389/fpsyt.2019.00025
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cerebrospinal fluid D -serine concentrations in major depressive disorder negatively correlate with depression severity
- (2018) Sayuri Ishiwata et al. JOURNAL OF AFFECTIVE DISORDERS
- d -Serine administration affects nitric oxide synthase 1 adaptor protein and DISC1 expression in sex-specific manner
- (2018) Kirsten C. Svane et al. MOLECULAR AND CELLULAR NEUROSCIENCE
- Potential and Challenges for the Clinical Use of d-Serine As a Cognitive Enhancer
- (2018) Gerson D. Guercio et al. Frontiers in Psychiatry
- Association between increased serum d -serine and cognitive gains induced by intensive cognitive training in schizophrenia
- (2018) Rogerio Panizzutti et al. SCHIZOPHRENIA RESEARCH
- Acute Amino Acid d-Serine Administration, Similar to Ketamine, Produces Antidepressant-like Effects through Identical Mechanisms
- (2017) I-Hua Wei et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- Development of an UPLC–MS/MS method for simultaneous quantitation of 11 d -amino acids in different regions of rat brain: Application to a study on the associations of d -amino acid concentration changes and Alzheimer’s disease
- (2017) Zhe Li et al. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
- Astroglial versus Neuronal D-Serine: Fact Checking
- (2017) Thomas Papouin et al. TRENDS IN NEUROSCIENCES
- Epigenetic Activation of ASCT2 in the Hippocampus Contributes to Depression-Like Behavior by Regulating D-Serine in Mice
- (2017) Jiesi Wang et al. Frontiers in Molecular Neuroscience
- ON or OFF?: Modulating the N-Methyl-D-Aspartate Receptor in Major Depression
- (2017) Shi Yu Chan et al. Frontiers in Molecular Neuroscience
- Improvement in mismatch negativity generation during d-serine treatment in schizophrenia: Correlation with symptoms
- (2017) Joshua T. Kantrowitz et al. SCHIZOPHRENIA RESEARCH
- Neurophysiological mechanisms of cortical plasticity impairments in schizophrenia and modulation by the NMDA receptor agonist D-serine
- (2016) Joshua T. Kantrowitz et al. BRAIN
- Regulating levels of the neuromodulatord-serine in human brain: structural insight into pLG72 andd-amino acid oxidase interaction
- (2016) Leila Birolo et al. FEBS Journal
- Modulating NMDA Receptor Function with d-Amino Acid Oxidase Inhibitors: Understanding Functional Activity in PCP-Treated Mouse Model
- (2016) Henry Sershen et al. NEUROCHEMICAL RESEARCH
- Low d-serine levels in schizophrenia: A systematic review and meta-analysis
- (2016) Seo-Eun Cho et al. NEUROSCIENCE LETTERS
- The Rise and Fall of the d -Serine-Mediated Gliotransmission Hypothesis
- (2016) Herman Wolosker et al. TRENDS IN NEUROSCIENCES
- D-Serine and Serine Racemase Are Associated with PSD-95 and Glutamatergic Synapse Stability
- (2016) Hong Lin et al. Frontiers in Cellular Neuroscience
- Supplementation with D-serine prevents the onset of cognitive deficits in adult offspring after maternal immune activation
- (2016) Yuko Fujita et al. Scientific Reports
- Increased serum levels of serine enantiomers in patients with depression
- (2015) Kenji Hashimoto et al. ACTA NEUROPSYCHIATRICA
- Enantioselective inhibition ofd-serine transport by (S)-ketamine
- (2015) Nagendra S Singh et al. BRITISH JOURNAL OF PHARMACOLOGY
- The NMDA receptor ‘glycine modulatory site’ in schizophrenia: d-serine, glycine, and beyond
- (2015) Darrick T Balu et al. CURRENT OPINION IN PHARMACOLOGY
- Serine enantiomers as diagnostic biomarkers for schizophrenia and bipolar disorder
- (2015) Kenji Hashimoto EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- d-Aspartate: An endogenous NMDA receptor agonist enriched in the developing brain with potential involvement in schizophrenia
- (2015) Francesco Errico et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Behavioral and cognitive effects of the N-methyl-d-aspartate receptor co-agonist d-serine in healthy humans: Initial findings
- (2015) Raz Levin et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Effects of glutamate positive modulators on cognitive deficits in schizophrenia: a systematic review and meta-analysis of double-blind randomized controlled trials
- (2015) Y Iwata et al. MOLECULAR PSYCHIATRY
- Ketamine for depression: evidence, challenges and promise
- (2015) Carlos A. Zarate et al. World Psychiatry
- Increased serum levels of serine enantiomers in patients with depression
- (2015) Kenji Hashimoto et al. ACTA NEUROPSYCHIATRICA
- D-Serine in Neurobiology: CNS Neurotransmission and Neuromodulation
- (2014) Sanaa K. Bardaweel et al. CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES
- Serine Racemase Regulated by Binding to Stargazin and PSD-95
- (2014) Ting Martin Ma et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Chronic D-serine reverses arc expression and partially rescues dendritic abnormalities in a mouse model of NMDA receptor hypofunction
- (2014) Darrick T. Balu et al. NEUROCHEMISTRY INTERNATIONAL
- d-serine prevents cognitive deficits induced by acute stress
- (2014) G.D. Guercio et al. NEUROPHARMACOLOGY
- Disrupted-In-Schizophrenia-1 (DISC1) interactome and mental disorders: Impact of mouse models
- (2014) Tatiana V. Lipina et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Changes in plasma d-serine, l-serine, and glycine levels in treatment-resistant schizophrenia before and after clozapine treatment
- (2014) Hidenaga Yamamori et al. NEUROSCIENCE LETTERS
- D-serine plasma concentration is a potential biomarker of (R,S)-ketamine antidepressant response in subjects with treatment-resistant depression
- (2014) Ruin Moaddel et al. PSYCHOPHARMACOLOGY
- Rapid-Acting Glutamatergic Antidepressants: The Path to Ketamine and Beyond
- (2013) John H. Krystal et al. BIOLOGICAL PSYCHIATRY
- Adjunctive pharmacotherapy for cognitive deficits in schizophrenia: meta-analytical investigation of efficacy
- (2013) Kee-Hong Choi et al. BRITISH JOURNAL OF PSYCHIATRY
- D-Amino Acid Oxidase Inhibitors as a Novel Class of Drugs for Schizophrenia Therapy
- (2013) Silvia Sacchi et al. CURRENT PHARMACEUTICAL DESIGN
- Glutamate modulators as potential therapeutic drugs in schizophrenia and affective disorders
- (2013) Kenji Hashimoto et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- The degradation (by distinct pathways) of humand-amino acid oxidase and its interacting partner pLG72 - two key proteins ind-serine catabolism in the brain
- (2013) Pamela Cappelletti et al. FEBS Journal
- Distinctively higher plasma G72 protein levels in patients with schizophrenia than in healthy individuals
- (2013) C-H Lin et al. MOLECULAR PSYCHIATRY
- Neonatal Disruption of Serine Racemase Causes Schizophrenia-Like Behavioral Abnormalities in Adulthood: Clinical Rescue by D-Serine
- (2013) Hiroko Hagiwara et al. PLoS One
- Effects of Chronic D-Serine Elevation on Animal Models of Depression and Anxiety-Related Behavior
- (2013) David-Marian Otte et al. PLoS One
- Multiple risk pathways for schizophrenia converge in serine racemase knockout mice, a mouse model of NMDA receptor hypofunction
- (2013) D. T. Balu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A pilot double-blind comparison of d-serine and high-dose olanzapine in treatment-resistant patients with schizophrenia
- (2013) Marina Ermilov et al. SCHIZOPHRENIA RESEARCH
- D-serine as a gliotransmitter and its roles in brain development and disease
- (2013) Marion R. Van Horn et al. Frontiers in Cellular Neuroscience
- Add-on Treatment of Benzoate for Schizophrenia
- (2013) Hsien-Yuan Lane et al. JAMA Psychiatry
- Brain d-amino acids: a novel class of neuromodulators
- (2012) Jean-Pierre Mothet et al. AMINO ACIDS
- d-Amino acids in brain neurotransmission and synaptic plasticity
- (2012) Jean-Marie Billard AMINO ACIDS
- Clozapine, but not haloperidol, enhances glial d-serine and L-glutamate release in rat frontal cortex and primary cultured astrocytes
- (2012) Shunske Tanahashi et al. BRITISH JOURNAL OF PHARMACOLOGY
- Synaptic and Extrasynaptic NMDA Receptors Are Gated by Different Endogenous Coagonists
- (2012) Thomas Papouin et al. CELL
- d-serine and schizophrenia: an update
- (2012) Emerson A Nunes et al. Expert Review of Neurotherapeutics
- A Multicenter, Add-On Randomized Controlled Trial of Low-Dosed-Serine for Negative and Cognitive Symptoms of Schizophrenia
- (2012) Mark Weiser et al. JOURNAL OF CLINICAL PSYCHIATRY
- Pathogenic disruption of DISC1-serine racemase binding elicits schizophrenia-like behavior via D-serine depletion
- (2012) T M Ma et al. MOLECULAR PSYCHIATRY
- Neuronal d-serine regulates dendritic architecture in the somatosensory cortex
- (2012) Darrick T. Balu et al. NEUROSCIENCE LETTERS
- Plasma levels of D-serine in Brazilian individuals with schizophrenia
- (2012) Marilia A. Calcia et al. SCHIZOPHRENIA RESEARCH
- Clinical and Cerebral Volumetric Effects of Sodium Benzoate, a d-Amino Acid Oxidase Inhibitor, in a Drug-Naïve Patient with Major Depression
- (2011) Chien-Han Lai et al. BIOLOGICAL PSYCHIATRY
- Association between the DAOA/G72 gene and bipolar disorder and meta-analyses in bipolar disorder and schizophrenia
- (2011) Daniel J Müller et al. BIPOLAR DISORDERS
- Meta-Analysis of the Efficacy of Adjunctive NMDA Receptor Modulators in Chronic Schizophrenia
- (2011) Surendra P. Singh et al. CNS DRUGS
- Recent Advances in the Discovery of D-Amino Acid Oxidase Inhibitors and Their Therapeutic Utility in Schizophrenia
- (2011) Dana V. Ferraris et al. CURRENT PHARMACEUTICAL DESIGN
- Effect of D-amino acid oxidase activator (DAOA; G72) on brain function during verbal fluency
- (2011) Diana P. Prata et al. HUMAN BRAIN MAPPING
- Acute d-serine treatment produces antidepressant-like effects in rodents
- (2011) Oz Malkesman et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Evidence for the interaction of d-amino acid oxidase with pLG72 in a glial cell line
- (2011) Silvia Sacchi et al. MOLECULAR AND CELLULAR NEUROSCIENCE
- The NMDA receptor co-agonists, d-serine and glycine, regulate neuronal dendritic architecture in the somatosensory cortex
- (2011) Darrick T. Balu et al. NEUROBIOLOGY OF DISEASE
- Contributions of the d-serine pathway to schizophrenia
- (2011) Viviane Labrie et al. NEUROPHARMACOLOGY
- Glutamate signaling in the pathophysiology and therapy of schizophrenia
- (2011) Chieh-Hsin Lin et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Effects of low-dose d-serine on recognition and working memory in mice
- (2011) Patricia Bado et al. PSYCHOPHARMACOLOGY
- N-methyl-d-aspartate (NMDA) receptor dysfunction or dysregulation: The final common pathway on the road to schizophrenia?
- (2010) Joshua T. Kantrowitz et al. BRAIN RESEARCH BULLETIN
- Strategies to Enhance N-Methyl-D-Aspartate Receptor-Mediated Neurotransmission in Schizophrenia, a Critical Review and Meta-Analysis
- (2010) Guochuan Tsai et al. CURRENT PHARMACEUTICAL DESIGN
- Serine racemase deletion disrupts memory for order and alters cortical dendritic morphology
- (2010) L. M. DeVito et al. GENES BRAIN AND BEHAVIOR
- Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders
- (2010) Giles E. Hardingham et al. NATURE REVIEWS NEUROSCIENCE
- Effect of ligand binding on human D-amino acid oxidase: Implications for the development of new drugs for schizophrenia treatment
- (2010) Laura Caldinelli et al. PROTEIN SCIENCE
- d-Serine and a glycine transporter-1 inhibitor enhance social memory in rats
- (2010) Toshiharu Shimazaki et al. PSYCHOPHARMACOLOGY
- High dose D-serine in the treatment of schizophrenia
- (2010) Joshua T. Kantrowitz et al. SCHIZOPHRENIA RESEARCH
- Co-Administration of a D-Amino Acid Oxidase Inhibitor Potentiates the Efficacy of D-Serine in Attenuating Prepulse Inhibition Deficits After Administration of Dizocilpine
- (2009) Kenji Hashimoto et al. BIOLOGICAL PSYCHIATRY
- Genetic loss of D-amino acid oxidase activity reverses schizophrenia-like phenotypes in mice
- (2009) V. Labrie et al. GENES BRAIN AND BEHAVIOR
- Serine racemase is associated with schizophrenia susceptibility in humans and in a mouse model
- (2009) Viviane Labrie et al. HUMAN MOLECULAR GENETICS
- Increased d-amino acid oxidase expression in the bilateral hippocampal CA4 of schizophrenic patients: a post-mortem study
- (2009) Gregor Habl et al. JOURNAL OF NEURAL TRANSMISSION
- The neurobiology of D-amino acid oxidase and its involvement in schizophrenia
- (2009) L Verrall et al. MOLECULAR PSYCHIATRY
- The involvement of the NMDA receptor d-serine/glycine site in the pathophysiology and treatment of schizophrenia
- (2009) Viviane Labrie et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- pLG72 Modulates Intracellular D-Serine Levels through Its Interaction with D-Amino Acid Oxidase
- (2008) Silvia Sacchi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Synthesis and Biological Evaluation ofd-Amino Acid Oxidase Inhibitors
- (2008) Dana Ferraris et al. JOURNAL OF MEDICINAL CHEMISTRY
- Changes in plasma glycine, l-serine, and d-serine levels in patients with schizophrenia as their clinical symptoms improve: Results from the Juntendo University Schizophrenia Projects (JUSP)
- (2008) Tohru Ohnuma et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Increased brain d-amino acid oxidase (DAAO) activity in schizophrenia
- (2008) Caroline Madeira et al. SCHIZOPHRENIA RESEARCH
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started